Jenkins joins Dimension as CEO

Dimension Therapeutics (Cambridge, Mass.) hired Annalisa Jenkins as CEO. She previously was EVP and head of global R&D at the Merck Serono S.A. biopharmaceutical division of Merck KGaA (Xetra:MRK). Jenkins succeeds Dimension interim CEO Thomas Beck, who is an executive partner at Dimension investor Fidelity BioSciences. ...